Borg C - Search Results

1

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.

Dobi E, Monnien F, Kim S, Ivanaj A, N'Guyen T, Demarchi M, Adotevi O, Thierry-Vuillemin A, Jary M, Kantelip B, Pivot X, Godet Y, Degano SV, Borg C. Dobi E, et al. Among authors: borg c. Clin Colorectal Cancer. 2013 Mar;12(1):28-36. doi: 10.1016/j.clcc.2012.09.002. Epub 2012 Oct 17. Clin Colorectal Cancer. 2013. PMID: 23083634

2

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.

Borg C, Ray-Coquard I, Philip I, Clapisson G, Bendriss-Vermare N, Menetrier-Caux C, Sebban C, Biron P, Blay JY. Borg C, et al. Cancer. 2004 Dec 1;101(11):2675-80. doi: 10.1002/cncr.20688. Cancer. 2004. PMID: 15503313 Free article.

3

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation.

Pallandre JR, Krzewski K, Bedel R, Ryffel B, Caignard A, Rohrlich PS, Pivot X, Tiberghien P, Zitvogel L, Strominger JL, Borg C. Pallandre JR, et al. Among authors: borg c. Blood. 2008 Dec 1;112(12):4420-4. doi: 10.1182/blood-2007-12-126888. Epub 2008 Aug 5. Blood. 2008. PMID: 18682600 Free PMC article.

4

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.

Guiu B, Petit JM, Bonnetain F, Ladoire S, Guiu S, Cercueil JP, Krausé D, Hillon P, Borg C, Chauffert B, Ghiringhelli F. Guiu B, et al. Among authors: borg c. Gut. 2010 Mar;59(3):341-7. doi: 10.1136/gut.2009.188946. Epub 2009 Oct 15. Gut. 2010. PMID: 19837679

5

Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial.

Monnien F, Zaki H, Borg C, Mougin C, Bosset JF, Mercier M, Arbez-Gindre F, Kantelip B. Monnien F, et al. Among authors: borg c. J Clin Pathol. 2010 Oct;63(10):873-8. doi: 10.1136/jcp.2010.076414. J Clin Pathol. 2010. PMID: 20876317 Clinical Trial.

6

Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.

Bedel R, Thiery-Vuillemin A, Grandclement C, Balland J, Remy-Martin JP, Kantelip B, Pallandre JR, Pivot X, Ferrand C, Tiberghien P, Borg C. Bedel R, et al. Among authors: borg c. Cancer Res. 2011 Mar 1;71(5):1615-26. doi: 10.1158/0008-5472.CAN-09-4540. Epub 2011 Jan 21. Cancer Res. 2011. PMID: 21257710

7

Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

Curtit E, Thiery-Vuillemin A, Nguyen T, Heyd B, Pivot X, Di Martino V, Borg C. Curtit E, et al. Among authors: borg c. J Clin Oncol. 2011 Apr 20;29(12):e330-2. doi: 10.1200/JCO.2010.32.6785. Epub 2011 Jan 24. J Clin Oncol. 2011. PMID: 21263091 No abstract available.

8

A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers.

Magnin S, Viel E, Baraquin A, Valmary-Degano S, Kantelip B, Pretet JL, Mougin C, Bigand M, Girardo B, Borg C, Ferrand C. Magnin S, et al. Among authors: borg c. J Mol Diagn. 2011 Sep;13(5):485-92. doi: 10.1016/j.jmoldx.2011.05.010. Epub 2011 Jul 8. J Mol Diagn. 2011. PMID: 21742054 Free PMC article.

9

Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells.

Grandclement C, Pallandre JR, Valmary Degano S, Viel E, Bouard A, Balland J, Rémy-Martin JP, Simon B, Rouleau A, Boireau W, Klagsbrun M, Ferrand C, Borg C. Grandclement C, et al. Among authors: borg c. PLoS One. 2011;6(7):e20444. doi: 10.1371/journal.pone.0020444. Epub 2011 Jul 1. PLoS One. 2011. PMID: 21747928 Free PMC article.

10

Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.

Bennouna J, Borg C, Delord JP, Husseini F, Trillet-Lenoir V, Faroux R, François E, Ychou M, Goldwasser F, Bouché O, Senellart H, Kraemer S, Douillard JY. Bennouna J, et al. Among authors: borg c. Clin Colorectal Cancer. 2012 Mar;11(1):38-44. doi: 10.1016/j.clcc.2011.05.002. Epub 2011 Jul 29. Clin Colorectal Cancer. 2012. PMID: 21803002 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

454 results

Search Page